Abstract
Proto-oncoproteins are a heterogeneous group of proteins that induce cellular differentiation, proliferation and growth, acting at different points of signaling cascades and in different cell compartments, through many different mechanisms. If the proto-oncogenes that give raise to proto-oncoproteins undergo genetic damage, they become oncogenes and their products are the oncoproteins responsible for cellular transformation in cancer. Some proto-oncoproteins are related to membranes and they exert their function at this level. Among these are receptors and receptor-like growth factors, membrane associated tyrosine kinases, and small GTPases. Other proto-oncoproteins are transcription factors and as such, their best known functional context is promoter DNA regions. Consequently, DNA is widely viewed as their most relevant non protein partner. Any interaction of these proteins with membranes is generally overlooked and, when considered, the membrane is regarded as a reservoir for timely release requiring proteolytic activity. However, this status quo should be revised. Some Immediate-Early proteins that are mobilized in the cell shortly after stimulus are also a subset of the transcription factor kind of proto-oncoproteins. These particular Immediate-Early proto- Oncoproteins (IEOs) exceed strict DNA related functions. Gathering evidence coming from biophysical studies on one hand and from molecular and cellular studies on the other hand, converge suggesting a link between them and membranes. In this review we discuss the conception that transcription factors with the features of IEOs exert their function in cellular processes, not only through association to DNA related to targeted transcription, but also through association to membranes related to global replication and transcription.
Keywords: Amphitropic proteins, c-Fos, c-Myc, oncoproteins, DNA, proto-oncoproteins, c-Jun, Fra-1, epigenetic coupling, IEOs
Current Protein & Peptide Science
Title: Immediate Early Proto-Oncoproteins and Membranes: Not Just An Innocent Liaison
Volume: 12 Issue: 8
Author(s): Graciela A. Borioli
Affiliation:
Keywords: Amphitropic proteins, c-Fos, c-Myc, oncoproteins, DNA, proto-oncoproteins, c-Jun, Fra-1, epigenetic coupling, IEOs
Abstract: Proto-oncoproteins are a heterogeneous group of proteins that induce cellular differentiation, proliferation and growth, acting at different points of signaling cascades and in different cell compartments, through many different mechanisms. If the proto-oncogenes that give raise to proto-oncoproteins undergo genetic damage, they become oncogenes and their products are the oncoproteins responsible for cellular transformation in cancer. Some proto-oncoproteins are related to membranes and they exert their function at this level. Among these are receptors and receptor-like growth factors, membrane associated tyrosine kinases, and small GTPases. Other proto-oncoproteins are transcription factors and as such, their best known functional context is promoter DNA regions. Consequently, DNA is widely viewed as their most relevant non protein partner. Any interaction of these proteins with membranes is generally overlooked and, when considered, the membrane is regarded as a reservoir for timely release requiring proteolytic activity. However, this status quo should be revised. Some Immediate-Early proteins that are mobilized in the cell shortly after stimulus are also a subset of the transcription factor kind of proto-oncoproteins. These particular Immediate-Early proto- Oncoproteins (IEOs) exceed strict DNA related functions. Gathering evidence coming from biophysical studies on one hand and from molecular and cellular studies on the other hand, converge suggesting a link between them and membranes. In this review we discuss the conception that transcription factors with the features of IEOs exert their function in cellular processes, not only through association to DNA related to targeted transcription, but also through association to membranes related to global replication and transcription.
Export Options
About this article
Cite this article as:
A. Borioli Graciela, Immediate Early Proto-Oncoproteins and Membranes: Not Just An Innocent Liaison, Current Protein & Peptide Science 2011; 12 (8) . https://dx.doi.org/10.2174/138920311798841690
DOI https://dx.doi.org/10.2174/138920311798841690 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
Call for Papers in Thematic Issues
Advancements in Proteomic and Peptidomic Approaches in Cancer Immunotherapy: Unveiling the Immune Microenvironment
The scope of this thematic issue centers on the integration of proteomic and peptidomic technologies into the field of cancer immunotherapy, with a particular emphasis on exploring the tumor immune microenvironment. This issue aims to gather contributions that illustrate the application of these advanced methodologies in unveiling the complex interplay ...read more
Artificial Intelligence for Protein Research
Protein research, essential for understanding biological processes and creating therapeutics, faces challenges due to the intricate nature of protein structures and functions. Traditional methods are limited in exploring the vast protein sequence space efficiently. Artificial intelligence (AI) and machine learning (ML) offer promising solutions by improving predictions and speeding up ...read more
Nutrition and Metabolism in Musculoskeletal Diseases
The musculoskeletal system consists mainly of cartilage, bone, muscles, tendons, connective tissue and ligaments. Balanced metabolism is of vital importance for the homeostasis of the musculoskeletal system. A series of musculoskeletal diseases (for example, sarcopenia, osteoporosis) are resulted from the dysregulated metabolism of the musculoskeletal system. Furthermore, metabolic diseases (such ...read more
Protein Folding, Aggregation and Liquid-Liquid Phase Separation
Protein folding, misfolding and aggregation remain one of the main problems of interdisciplinary science not only because many questions are still open, but also because they are important from the point of view of practical application. Protein aggregation and formation of fibrillar structures, for example, is a hallmark of a ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Connexins as Precocious Markers and Molecular Targets for Chemical and Pharmacological Agents in Carcinogenesis
Current Medicinal Chemistry SUBJECT INDEX TO VOLUME 1
Current Genomics Aurora B Kinase and Passenger Proteins as Targets for Cancer Therapy
Current Enzyme Inhibition Ω-3 Polyunsaturated Fatty Acids and Immune-Mediated Diseases: Inflammatory Bowel Disease and Rheumatoid Arthritis
Current Pharmaceutical Design The SCF-type E3 Ubiquitin Ligases as Cancer Targets
Current Cancer Drug Targets Potential Impacts of Prebiotics and Probiotics on Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry Druggability of Mortalin for Cancer and Neuro-Degenerative Disorders
Current Pharmaceutical Design Prophylactic Vaccine Approach for Colon and Pancreatic Cancers: Present and Future
Current Medicinal Chemistry Multimodal HDAC Inhibitors with Improved Anticancer Activity
Current Cancer Drug Targets Prognostic Markers in Small Cell Lung Cancer
Current Cancer Therapy Reviews Infringement of the Barriers of Cancer Via Dietary Phytoconstituents Capsaicin Through Novel Drug Delivery System
Current Drug Delivery Imaging of HER-2 Overexpression in Tumors for Guiding Therapy
Current Pharmaceutical Design MEET THE GUEST EDITOR [Hot Topic: Modern Omics-Based Platform for High Throughput Screening for Novel Drug Targets (Part 2) (Guest Editor: Canhua Huang)]
Combinatorial Chemistry & High Throughput Screening Resistance to Radiotherapy and Targeted Molecular Therapies in Squamous Cell Carcinomas of the Head and Neck, Preclinical Data and New Approaches
Current Signal Transduction Therapy Emerging Molecular Functions of MicroRNA-9: Cancer Pathology and Therapeutic Implications
Anti-Cancer Agents in Medicinal Chemistry Detection of Hepatitis B Virus-associated Hepatocellular Carcinoma Disease Using Hybrid Hierarchical k-Means Clustering and SVM Algorithm
Current Bioinformatics The Use of HepaRG and Human Hepatocyte Data in Predicting CYP Induction Drug-Drug Interactions via Static Equation and Dynamic Mechanistic Modelling Approaches
Current Drug Metabolism Molecular Targets from VHL Studies into the Oxygen-Sensing Pathway
Current Cancer Drug Targets In Silico Design of Phenylbenzamide Derivatives Coupled to Pyrimidines as Novel hnRNP K Ligands Against Cancer
Current Bioactive Compounds DNA Methylation Markers in Lung Cancer
Current Genomics